Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...
Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.
AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “ ...
Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback